Author:
D'Souza Anita,Fretham Caitrin,Lee Stephanie J,Arora Mukta,Brunner Janet,Chhabra Saurabh,Devine Steven,Eapen Mary,Hamadani Mehdi,Hari Parameswaran,Pasquini Marcelo C,Perez Waleska,Phelan Rachel A,Riches Marcie L,Rizzo J Douglas,Saber Wael,Shaw Bronwen E,Spellman Stephen R,Steinert Patricia,Weisdorf Daniel J,Horowitz Mary M
Funder
National Heart, Lung, and Blood Institute
Biomedical Advanced Research and Development Authority
Office of Naval Research
Health Resources and Services Administration
National Cancer Institute
Subject
Transplantation,Hematology
Reference7 articles.
1. Indications for hematopoietic cell transplantation and immune effector cell therapy: guidelines from the American Society for Transplantation and Cellular Therapy;Kanate;Biol Blood Marrow Transplant,2020
2. National Institutes of Health: National Cancer Institute. FDA approves second CAR T-cell therapy for lymphoma. Available at: https://www.cancer.gov/news-events/cancer-currents-blog/2018/tisagenlecleucel-fda-lymphoma. Accessed April 27 2020.
3. US Food and Drug Administration. FDA approves axicabtagene ciloleucel for large B-cell lymphoma. Available at: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-axicabtagene-ciloleucel-large-b-cell-lymphoma. Accessed April 27 2020.
4. Use of chimeric antigen receptor T cell therapy in clinical practice for relapsed/refractory aggressive B cell non-Hodgkin lymphoma: an expert panel opinion from the American Society for Transplantation and Cellular Therapy;Jain;Biol Blood Marrow Transplant,2019
5. Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States;Muffly;Blood,2017
Cited by
308 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献